NO20003235L - Molekyldispersjonsmateriale med forbedret biotilgjengelighet - Google Patents

Molekyldispersjonsmateriale med forbedret biotilgjengelighet

Info

Publication number
NO20003235L
NO20003235L NO20003235A NO20003235A NO20003235L NO 20003235 L NO20003235 L NO 20003235L NO 20003235 A NO20003235 A NO 20003235A NO 20003235 A NO20003235 A NO 20003235A NO 20003235 L NO20003235 L NO 20003235L
Authority
NO
Norway
Prior art keywords
improved bioavailability
dispersion material
molecular dispersion
molecular
bioavailability
Prior art date
Application number
NO20003235A
Other languages
English (en)
Other versions
NO327383B1 (no
NO20003235D0 (no
Inventor
Surendra A Sangekar
Ping I Lee
Amin A Nomeir
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20003235D0 publication Critical patent/NO20003235D0/no
Publication of NO20003235L publication Critical patent/NO20003235L/no
Publication of NO327383B1 publication Critical patent/NO327383B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20003235A 1997-12-22 2000-06-21 Farmasoytisk formulering omfattende molekyldispersjonsmateriale med forbedret biotilgjengelighet NO327383B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99716897A 1997-12-22 1997-12-22
PCT/US1998/026218 WO1999032118A1 (en) 1997-12-22 1998-12-17 Molecular dispersion composition with enhanced bioavailability

Publications (3)

Publication Number Publication Date
NO20003235D0 NO20003235D0 (no) 2000-06-21
NO20003235L true NO20003235L (no) 2000-07-27
NO327383B1 NO327383B1 (no) 2009-06-22

Family

ID=25543717

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003235A NO327383B1 (no) 1997-12-22 2000-06-21 Farmasoytisk formulering omfattende molekyldispersjonsmateriale med forbedret biotilgjengelighet

Country Status (27)

Country Link
EP (1) EP1039908B1 (no)
JP (2) JP2001526227A (no)
KR (1) KR100597331B1 (no)
CN (1) CN1116039C (no)
AR (1) AR017436A1 (no)
AT (1) ATE260105T1 (no)
AU (1) AU761994C (no)
BR (1) BR9813728A (no)
CA (1) CA2315685C (no)
CO (1) CO4970793A1 (no)
CZ (1) CZ295956B6 (no)
DE (1) DE69821984T2 (no)
DK (1) DK1039908T3 (no)
ES (1) ES2214757T3 (no)
HU (1) HU229052B1 (no)
ID (1) ID28304A (no)
IL (1) IL136460A0 (no)
MY (1) MY126580A (no)
NO (1) NO327383B1 (no)
NZ (1) NZ504834A (no)
PE (1) PE20000012A1 (no)
PL (1) PL192423B1 (no)
PT (1) PT1039908E (no)
SK (1) SK285662B6 (no)
TW (1) TW527196B (no)
WO (1) WO1999032118A1 (no)
ZA (1) ZA9811592B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
MXPA03011784A (es) 2001-06-22 2004-04-02 Pfizer Prod Inc Composiciones farmaceuticas de dispersiones de farmacos y polimeros neutros.
KR20100049695A (ko) * 2002-03-04 2010-05-12 테바 파마슈티컬 인더스트리즈 리미티드 방출 조절 제형
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
PT103661B (pt) 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
WO2008136394A1 (ja) * 2007-04-27 2008-11-13 Ajinomoto Co., Inc. ラクタム化合物の製造方法及びその製造中間体
US8835635B2 (en) * 2012-06-05 2014-09-16 Symed Labs Limited Amorphous form of vilazodone hydrochloride substantially free of crystalline forms
WO2016198983A1 (en) 2015-06-09 2016-12-15 Bend Research Inc. Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
EP0214092A1 (en) * 1985-08-08 1987-03-11 Ciba-Geigy Ag Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone
SG43179A1 (en) * 1991-12-18 1997-10-17 Warner Lambert Co A process for the prepatation of a solid dispersion
JPH0848632A (ja) * 1994-08-08 1996-02-20 Kanebo Ltd エトポシドを含有する固形組成物および固形製剤
SK86198A3 (en) * 1995-12-22 1999-02-11 Schering Corp Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases
DE69730241T2 (de) * 1996-06-28 2005-08-11 Schering Corp. Feste lösung eines fungizids mit erhöhter bioverfügbarkeit

Also Published As

Publication number Publication date
CN1116039C (zh) 2003-07-30
WO1999032118A1 (en) 1999-07-01
NO327383B1 (no) 2009-06-22
HU229052B1 (en) 2013-07-29
EP1039908A1 (en) 2000-10-04
DE69821984T2 (de) 2004-12-30
TW527196B (en) 2003-04-11
NZ504834A (en) 2001-12-21
PT1039908E (pt) 2004-06-30
JP2010059212A (ja) 2010-03-18
AR017436A1 (es) 2001-09-05
CO4970793A1 (es) 2000-11-07
CZ295956B6 (cs) 2005-12-14
SK8962000A3 (en) 2001-07-10
ID28304A (id) 2001-05-10
EP1039908B1 (en) 2004-02-25
ES2214757T3 (es) 2004-09-16
AU761994C (en) 2004-01-08
HUP0100850A3 (en) 2002-12-28
KR20010033397A (ko) 2001-04-25
CA2315685A1 (en) 1999-07-01
KR100597331B1 (ko) 2006-07-10
PL192423B1 (pl) 2006-10-31
SK285662B6 (sk) 2007-05-03
AU761994B2 (en) 2003-06-12
DK1039908T3 (da) 2004-05-03
PE20000012A1 (es) 2000-01-18
BR9813728A (pt) 2000-10-10
JP2001526227A (ja) 2001-12-18
AU1814399A (en) 1999-07-12
NO20003235D0 (no) 2000-06-21
IL136460A0 (en) 2001-06-14
CN1282245A (zh) 2001-01-31
DE69821984D1 (de) 2004-04-01
ATE260105T1 (de) 2004-03-15
HUP0100850A2 (hu) 2001-10-28
ZA9811592B (en) 1999-06-17
HK1027040A1 (en) 2001-01-05
CZ20002304A3 (cs) 2001-04-11
CA2315685C (en) 2008-02-05
MY126580A (en) 2006-10-31
PL341344A1 (en) 2001-04-09

Similar Documents

Publication Publication Date Title
DE69802670D1 (de) Flash-gesponnenes flächiges material
DK1039922T3 (da) Forbedrede interferonpolymerkonjugater
FR2763699B1 (fr) Detecteur-optoelectronique
DE69807509D1 (de) Vernetzbare polyharnstoffpolymere
DE69822656D1 (de) Formmasse
ID24176A (id) Bahan pembantu sementasi
FR1070751T (fr) Materiau de friction
ID27882A (id) Bahan tambahan karet termikroenkapsulasi
DE60008046D1 (de) Reibungsmaterial
FI20000371L (fi) Aineen prosessointi
NO20000014D0 (no) Grohemmende polymerer
DE69922710D1 (de) Gasadsorbierendes material
FI971338A7 (fi) Muovipohjainen materiaali
NO981126L (no) Forbedret katalysatorbærermateriale
DE69823654T8 (de) Zwei-lagen bedruckbares material
NO984001D0 (no) Material-transportsystem
DE69834448D1 (de) Kontaktwerkstoffe
FI972210A0 (fi) Icke-svettdrivande material
NO20031437D0 (no) Måling-under-boring-anordninger med stötputemonterte fölere
FI974634A0 (fi) Anordning foer matning av material
NO20003235D0 (no) Molekyldispersjonsmateriale med forbedret biotilgjengelighet
FR2765244B1 (fr) Materiau de frottement
DE69801028D1 (de) Adsorbens
NO993662D0 (no) Polymerer
DE69832430D1 (de) PTC-Verbundmaterial

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP AND DOHME CORP

Free format text: NEW ADDRESS: 126 EAST LINCOLN AVENUE, US-NJ07065 RAHWAY, US

MM1K Lapsed by not paying the annual fees